Elise Paeffgen is quoted on the U.S. Environmental Protection Agency’s new rule on aerosol can waste and what it means for industry stakeholders.
In the News
January 22, 2020
Waste360 | EPA’s New Rule on Aerosol Cans: What it Means for Who
Related News & Insights
-
In the News June 3, 2019Waste360 | Navigating EPA’s Hazardous Waste Pharmaceuticals Rulemaking (Part One)Elise Paeffgen is quoted on how U.S. Environmental Protection Agency standards for hazardous waste pharmaceuticals could impact healthcare providers, retailers, pharmacies, and reverse distributors.
-
Advisories January 19, 2021Federal Tax Advisory: 45Q Regulations Will Spur Carbon Capture and Storage InvestmentCarbon capture and storage could play a major role in a Biden Administration eager to rejoin the Paris Agreement. Our Federal Tax Group provides a brief overview of the 45Q credit and key takeaways from the IRS’s new final regulations.
-
In the News March 30, 2020Inside EPA | EPA Makes Case-Specific Cleanup Decisions as Virus Drives Health FearsElise Paeffgen comments on the flexibility being given by the U.S. Environmental Protection Agency to hazardous waste generators for transferring waste during the coronavirus pandemic.
-
In the News March 12, 2020Waste360 | Long-Term Care Providers Adjust to Hazardous Pharmaceutical Waste RuleElise Paeffgen comments on long-term care facilities’ implementation of the U.S. Environmental Protection Agency’s final pharmaceutical waste rule.
-
Press Release March 2, 2020Alston & Bird Announces COVID-19 Coronavirus Task ForceAlston & Bird has formed a working group to advise clients on the business and legal implications of the COVID-19 coronavirus.
Media Contact
- Environment, Land Use & Natural Resources
- Environmental Enforcement Defense
- Internal Investigations & Environmental Audits
- Chemical & Product Regulation
- Hazardous Materials & Hazardous Waste Compliance
- Air Quality
- Environmental Compliance, Permitting & Transactions
- Pesticide Law and Regulation, Enforcement and Registration
- FDA/Food, Drug & Device